Resistance to targeted therapies in lymphomas / Ana C. Xavier, Mitchell S. Cairo, editors.
Xavier, Ana C.; Cairo, Mitchell S., 1950-
2019
RC280.L9
Available Online

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
Resistance to targeted therapies in lymphomas / Ana C. Xavier, Mitchell S. Cairo, editors.
ISBN
9783030244248 (electronic book)
3030244245 (electronic book)
DOI
https://doi.org/10.1007/978-3-030-24
Publication Details
Cham : Springer, 2019.
Language
English
Description
1 online resource (220 pages).
Item Number
10.1007/978-3-030-24
Call Number
RC280.L9
Dewey Decimal Classification
616.99446
Summary
This volume will review different classes of "target" drugs that have been developed, approved, or are under investigation in the field of lymphoma therapy. The discussion will not only be on the understanding of the mechanisms of action or clinical response of those agents, but also help the reader to understand the nature of lymphoma biology in patients who relapse or are refractor after exposure to those drugs. Contributors will discuss what is currently known about mechanisms of tumor-related or host-related resistance, and how to overcome this resistance. This understanding is crucial given the dismal outcomes of patients with relapsed or refractory lymphomas. The book provides a unique opportunity to review and reflect on the recent successes and pitfalls of the modern lymphoma therapy era.
Bibliography, etc. Note
Includes bibliographical references and index.
Access Note
Access limited to authorized users.
Source of Description
Online resource; title from PDF title page (SpringerLink, viewed September 25, 2019).
Added Author
Xavier, Ana C.
Cairo, Mitchell S., 1950-
Series
Resistance to targeted anti-cancer therapeutics ; v. 21.
Available in Other Form
Resistance to Targeted Therapies in Lymphomas
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
Mechanisms of Glucocorticoid Response and Resistance in Lymphoid Malignancies
Resistance to Monoclonal Antibody Therapeutics in Lymphoma
Resistance to Antibody-Drug Conjugate
Resistance to Proteasome Inhibitor Therapy in Non-Hodgkin Lymphoma
Resistance to Histone Deacetylase Inhibitors in the Treatment of Lymphoma
Resistance to Brutons Tyrosine Kinase Signaling Pathway Targeted Therapies
Resistance to Checkpoint Blockade Inhibitors and Immunomodulatory Drugs
Resistance to Bispecific T-cell Engagers and Bispecific Antibodies
Resistance to Chimeric antigen receptor T-cell therapy
Index.

Browse Subjects

Show more subjects...

Statistics

from
to
Export